🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Heyyy #GBDoc - one of our team found a relic of diabetes technology in the back of the cupboard. Help us figure out what it is! Any ideas? UHDB Diabetes & Endocrinology

Prediction of progression to type 1 #diabetes with dynamic biomarkers and risk scores thelancet.com/journals/landi… #T1D

Is Metformin Cardioprotective? A New Piece to the Puzzle. Journal of Cardiovascular Pharmacology 84(2):p 155-157, August 2024.

Metabolomics and genetics analyses identified metabolite biomarkers associated with kidney function decline and their genetic determinants in multi-ethnic Asian individuals with type 2 diabetes #T2D #CKD #DiabetesResearch #Metabolomics #Genetics tinyurl.com/3dp7ps46

The use of SGLT2i is associated with a decreased risk of adverse clinical outcomes among patients with HCM with concurrent diabetes on antidiabetic drugs academic.oup.com/eurjpc/advance… European Society of Cardiology Victor Aboyans Silvia Castelletti Francesco Perone Andrea Gallardo #cvprev

Normal Chest X-Ray 🩻

The potential role for artificial intelligence in fracture risk prediction thelancet.com/journals/landi… #ArtificialIntelligence #AI #MachineLearning #osteoporosis #BoneHealth #fractures #BMD

🌟 OBESITY - Medications

🔴Vasodilators – Overview⤵️ 🔹manualofmedicine.com/topics/pharmac… #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical #medEd #cardiotwitter #medicineball #GDMT #HFrEF

1/ Studies of twins show 40–70% of obesity is genetic. But how can genes explain the obesity epidemic when our genes haven’t changed? Let me share a story about how genes and environment shape obesity—and what it means for a kinder, healthier 🌎. A 🧵

New—Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment thelancet.com/journals/landi… #MASLD #OpenAccess

Upper GI physiology

🫘AKI CKD Classification By Pyrls

Every week, I see a new study talking about this or that effect of GLP-1 receptor agonists like #ozempic. FINALLY, we have a study evaluating all the outcomes (good and bad) in one dataset. There are some... surprises. 🧵

A new review describes basic and translational research on the complex physiological processes of hunger, which regulate feeding habits and are influenced by socioeconomic, cultural, and behavioral factors. Read the full review: nej.md/3C8CHAn

As the new generation of GLP-1 medicines approaches, exciting new opportunities to assess the benefits and safety profile of new combinations diabetesjournals.org/care/article/4…

Obesity accelerates cardiovascular ageing. Read this State-of-the-Art review just published in #EHJ 👉 ow.ly/3k5g50VyHX4 Rocco Montone EHJ Editor-in-Chief #obesity

Phase 3 results from ACHIEVE-1, for oral small molecule GLP-1 receptor agonist #orforglipron in type 2 diabetes. Modest results with A1c decrease of 1.3% to 1.6% and an 8% average weight loss at the highest dose. investor.lilly.com/news-releases/…

From evolution to revolution-an update on small molecule GLP-1 medicines, from crystal structure and drug design to the clinic Science Magazine #T2D #Obesity #Weightloss science.org/content/articl…